Literature DB >> 8195029

Radiolytic and photochemical reduction of the hypoxic cytotoxin 1,2-dihydro-8-(4-methylpiperazinyl)-4-phenylimidazo [1,2-a] pyrido [3,2-e] pyrazine 5-oxide (RB90740) and a potential mechanism for hypoxia-selective toxicity.

M A Naylor1, B M Sutton, J Nolan, P O'Neill, E M Fielden, G E Adams, I J Stratford.   

Abstract

PURPOSE: To study the reduction of RB90740 (1), a fused pyrazine mono-N-oxide that has an oxic:hypoxic cytotoxicity ratio of > 10 in a range of murine and human tumor cells in vitro. METHODS AND MATERIALS: Reduction of 1 has been initiated radiolytically and photochemically in aqueous solution and the products isolated and characterized by high performance liquid chromatography (HPLC).
RESULTS: Radiolytic reduction of 1 leads to the formation of the 2-electron reduced product, 2. The stoichiometry of the reduction is pH dependent, increasing from 1 to 2 with increasing pH, but independent of the presence of formate or 2-methyl 2-propanol in the reduction mixture. A dimerization product, 3, is also found, which is produced in greater yields at lower pH (< 6). Photochemical reduction of 1 to 2 was also found to be facile. Photolysis of 1 also leads to a deoxyribonucleic acid cleavage reaction.
CONCLUSION: Since 2 is not cytotoxic towards hypoxic cells at concentrations at which 1 is toxic, a probable candidate as the cytotoxic species under hypoxic conditions is the 1-electron reduced intermediate species.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195029     DOI: 10.1016/0360-3016(94)90285-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  2 in total

1.  Oncogenic potential of bifunctional bioreductive drugs.

Authors:  T K Hei; S X Liu; E J Hall
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  Chemical properties which control selectivity and efficacy of aromatic N-oxide bioreductive drugs.

Authors:  P Wardman; K I Priyadarsini; M F Dennis; S A Everett; M A Naylor; K B Patel; I J Stratford; M R Stratford; M Tracy
Journal:  Br J Cancer Suppl       Date:  1996-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.